Utama › Limfoma Folikular › North Carolina › Durham
Kajian klinikal Limfoma Folikular di Durham, NC
15 kajian untuk Limfoma Folikular sedang mencari peserta di lokasi dalam dan sekitar Durham (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)
Mengambil pesertaFasa 2/3
- Duke Cancer Center Clinic 1B/C Onc/Heme ( Site 1307), Durham
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular Lymphoma
Mengambil pesertaFasa 3
- University of North Carolina, Chapel Hill · 10 mi jauh
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- Duke Cancer Institute, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Mengambil pesertaFasa 1/2
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 10 mi jauh
Pain With Dementia
Mengambil pesertaSukarelawan sihat dialu-alukan
- Duke University Medical Center, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Mengambil pesertaFasa 1
- Duke University Medical Center, Durham
Combating Cancer-Related Fatigue: A Personalized Supportive Care Program
Mengambil peserta
- North Carolina Basnight Cancer Hospital, Chapel Hill · 10 mi jauh
Registry of Older Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
Study of SGR-1505 in Mature B-Cell Neoplasms
Mengambil pesertaFasa 1
- Duke University, Durham
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
Mengambil pesertaFasa 1
- Duke Univerisity, Durham
Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
Mengambil pesertaFasa 1
- Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill · 10 mi jauh
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
Mengambil pesertaFasa 1
- Duke University, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, Chapel Hill · 10 mi jauh
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Mengambil pesertaKajian pemerhatian
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 10 mi jauh
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Mengambil pesertaFasa 1
- University of North Carolina, Chapel Hill · 10 mi jauh
Kajian Limfoma Folikular di bandar lain
- New York City, NY24 kajian
- Milwaukee, WI19 kajian
- Nashville, TN18 kajian
- Houston, TX18 kajian
- Boston, MA17 kajian
- Baldwin Park, CA16 kajian
- Seattle, WA15 kajian
- Columbus, OH13 kajian
- Salt Lake City, UT13 kajian
- Chicago, IL12 kajian
- San Antonio, TX12 kajian
- Philadelphia, PA12 kajian
Kajian lain di Durham
- Kanser Payudara63 kajian
- Kanser (semua jenis)58 kajian
- Kanser Paru-paru Bukan Sel Kecil39 kajian
- Mieloma Pelbagai37 kajian
- Kanser Metastatik33 kajian
- Leukemia Mieloid Akut33 kajian
- Kanser Paru-paru32 kajian
- Kanser Prostat32 kajian
- Kanser Kolorektal28 kajian
- Leukemia Limfositik Kronik27 kajian
- Kanser Ovari27 kajian
- Kegagalan Jantung26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.